CNTN2 and neoplasm: Moreover, adoptive cell therapies (ACTs) targeting virally encoded tumor antigens like EBNA1 (EBV), E6/E7 (HPV), HBx (HBV), and Tax (HTLV-1) are under exploration (Zhang et al., 2024a).